US Patent

US8697748 — Glycogen or polysaccharide storage disease treatment method

Formulation · Assigned to Baylor Research Institute · Expires 2029-04-28 · 3y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a method for treating glycogen storage disease using a composition containing ketogenic odd carbon fatty acids.

USPTO Abstract

A method for treating glycogen storage disease by administering an effective amount of a composition that includes ketogenic odd carbon fatty acids that ameliorate the symptoms of these diseases.

Drugs covered by this patent

triheptanoin (TRIHEPTANOIN)

Patent Metadata

Patent number: US8697748
Jurisdiction: US
Classification: Formulation
Expires: 2029-04-28
Drug substance claim: No
Drug product claim: Yes
Assignee: Baylor Research Institute
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.